Orbactiv (Oritavancin) for Skin Infections: Single-Dose MRSA Treatment Explained (FDA 2014)
Sivextro (Tedizolid) for Skin Infections: 6-Day Oxazolidinone Treatment vs Linezolid (FDA 2014)
Vabomere (Meropenem/Vaborbactam) for Complicated UTIs: Carbapenem Combination for KPC Infections (FDA 2017)
Xacduro (Sulbactam/Durlobactam) for Acinetobacter Pneumonia: First Targeted Hospital Pneumonia Antibiotic (FDA 2023)
